Events

Upcoming Events
Date/Time Name Description Location
10/26/2017
12:30 AM - 1:30 AM
Test Event aaasdf adsfasdf
11/1/2017
11:30 AM - 1:00 PM
Piedmont Lithium-2017 Piedmont Lithium---PLL.ASX, PLLLY--Nasdaq is an Australian company with US assets. The Company has just begun trading on Nasdaq. The Company is benefiting from the growing global demand for lithium as a component of the lithium ion battery. The Company is operating in what has historically been the largest source of hard rock lithium globally. Much of the South American lithium production from other companies is shipped to nearby plants for processing and distribution to the North American market. The Racquet Club of Philadelphia
11/2/2017
5:00 PM - 8:30 PM
PSA Annual Meeting - 2017 Business Session 5:00-5:45pm Reception 5:45-6:30pm Dinner 6:30-8:30pm YOU MUST ATTEND THE BUSINESS SESSION IN ORDER TO ATTEND THE RECEPTION AND DINNER The Union League of Philadelphia
12/1/2017
11:30 AM - 1:00 PM
AstraZeneca PLC - 2017 AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company?s marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It primarily serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Eli Lilly and Company; Heptares Ltd.; French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom. The Racquet Club of Philadelphia
Past Events
Date/Time Name Description Location
10/17/2017
11:30 AM - 1:00 PM
Aytu BioScience, Inc.-2017 Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy. The Union League of Philadelphia
10/12/2017
4:00 PM - 7:00 PM
PSA Membership Event 2017 Guest speaker will be John Silvia, Chief Economist of Wells Fargo. John will speak about “Ten Issues as the Credit Cycle Matures” and other insights on the economy. A prerequisite for existing PSA Members to attend the event will be for you to bring a qualified prospective PSA Member to the event. Please provide the prospective members' name, email, telephone and affiliation. The Racquet Club of Philadelphia
10/11/2017
11:30 AM - 1:30 PM
Monmouth Real Estate Investment Corp., UMH Properties, Inc. - 2017 PLEASE NOTE: THIS EVENT WILL GO UNTIL 1:30 PM. MONMOUTH REAL ESTATE INVESTMENT CORPORATION Monmouth Real Estate Investment Corporation, founded in 1968, is one of the oldest public equity REITs in the U.S. The Company specializes in single-tenant, net-leased industrial properties, subject to long-term leases, primarily to investment grade tenants. Monmouth Real Estate Investment Corporation is a fully integrated and self-managed real estate company, whose property portfolio consists of 105 properties containing a total of approximately 17.9 million rentable square feet, geographically diversified across 30 states. In addition, the Company owns a portfolio of REIT securities. UMH PROPERTIES, INC. UMH Properties, Inc., which was organized in 1968, is a public equity REIT that owns and operates 107 manufactured home communities with approximately 19,400 developed homesites. These communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana, Michigan and Maryland. In addition, the Company owns a portfolio of REIT securities. PLEASE NOTE: THIS EVENT WILL GO UNTIL 1:30 PM. The Union League of Philadelphia
10/5/2017
11:30 AM - 1:00 PM
Onconova Therapeutics, Inc.-2017 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in the clinical stage and several pre-clinical programs. Advanced clinical trials with the Company's lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. For more information, please visit http://www.onconova.com. The Union League of Philadelphia
9/19/2017
11:30 AM - 1:00 PM
White Square Chemical - 2017 The Racquet Club of Philadelphia
9/13/2017
11:30 AM - 1:00 PM
PreveCeutical Medical, Inc. - 2017 PreveCeutical Medical Inc., a biomedical company, researches and develops organic and nature identical products for prevention and curative therapies. It offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals that are extracted from Caribbean blue scorpion venom. The company is based in Vancouver, Canada. The Racquet Club of Philadelphia
9/7/2017
11:30 AM - 1:00 PM
AmeriGas Partners, LP - 2017 Amerigas Partners, L.P. is a holding company. The Company conducts its business principally through its subsidiary, AmeriGas Propane, L.P. (AmeriGas OLP), a Delaware limited partnership. AmeriGas Propane, Inc. is the Company’s general partner (the General Partner) and is responsible for managing its operations. The General Partner is a wholly owned subsidiary of UGI Corporation (UGI), a publicly traded company. The Partnership serves approximately 2 million residential, commercial, industrial, agricultural, wholesale and motor fuel customers in all 50 states from over 2,000 propane distribution locations. In addition to distributing propane, the Partnership also sells, installs and services propane appliances, including heating systems. The Partnership sells propane primarily to residential, commercial/industrial, motor fuel, agricultural and wholesale customers. The Union League of Philadelphia
8/22/2017
11:30 AM - 1:00 PM
BioVie, Inc. BioVie Inc. is a clinical-stage company pursuing the discovery, development, and commercialization of innovative drug therapies. The Company is currently focused on developing and commercializing BIV201, a novel approach to the treatment of ascites due to chronic liver cirrhosis. In March 2017, BioVie received notification from the FDA that it could initiate a Phase 2a US clinical trial. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. It has Orphan Drug designation for the most common of these complications, ascites, which represents a significant unmet medical need. The FDA has never approved any drug specifically for treating ascites. The Racquet Club of Philadelphia
7/25/2017
11:30 AM - 1:00 PM
RPM International, Inc. - 2017 RPM International Inc. owns subsidiaries that manufacture and market high-performance coatings, sealants and specialty chemicals, primarily for maintenance and improvement applications. RPM employs more than 13,000 people worldwide and operates 120 manufacturing facilities in 24 countries. Its products are sold in approximately 170 countries and territories. Fiscal 2016 sales were $4.8 billion, with 66 percent to industrial and specialty markets worldwide and the remaining 34 percent to consumers mainly in North America. RPM as an Investment Shares of the company's common stock are traded on the New York Stock Exchange under the symbol RPM and are owned by more than 500 institutional investors and 108,000 individuals. RPM's track record of 43 consecutive annual cash dividend increases places it in an elite category of less than half of one percent of all publicly-traded U.S. companies. Approximately 91% of RPM's stockholders of record participate in its Dividend Reinvestment Plan. The Racquet Club of Philadelphia
7/18/2017
11:30 AM - 1:00 PM
Jaguar Animal Health - 2017 Jaguar Animal Health, Inc. is an animal health company. It is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, and horses. Canalevia is its prescription drug product candidate, intended for treatment of various forms of diarrhea in dogs. Canalevia is a canine-specific formulation of crofelemer, an active pharmaceutical ingredient (API) isolated and purified from the Croton lechleri tree. It is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products to address needs in animal health. As of December 31, 2016, its pipeline includes prescription drug product candidates for nine indications across multiple species, and non-prescription products targeting seven species. Its product candidates include Canalevia, Species-specific formulations of crofelemer, Equilevia, Virend (topical), Species-specific formulations of NP-500, Neonorm Calf and Species-specific formulations of Neonorm. The Racquet Club of Philadelphia
7/13/2017
11:30 AM - 1:00 PM
American Gas Association - 2017 The American Gas Association, founded in 1918, represents more than 200 local energy companies that deliver clean natural gas throughout the United States. There are more than 71 million residential, commercial and industrial natural gas customers in the U.S., of which 94 percent — over 68 million customers — receive their gas from AGA members. Today, natural gas meets almost one-fourth of the United States’ energy needs. The Union League of Philadelphia
6/14/2017
11:30 AM - 1:00 PM
Connecticut Water - 2017 Connecticut Water Service, Inc. is the largest publicly traded water company based in New England. Through its wholly-owned public water utility subsidiaries, The Connecticut Water Company and The Maine Water Company, the Company provides drinking water to approximately 123,600 customers, or about 400,000 people, in 77 municipalities throughout the states of Connecticut and Maine. On Jan. 23, 2017 Connecticut Water Service, Inc. (Nasdaq:CTWS) today announced that its Board of Directors declared a quarterly cash dividend of $0.2825 per common share payable on March 15, 2017, for shareholders of record as of March 1, 2017. This quarterly dividend remains unchanged from the previous quarter and represents an annualized dividend of $1.13 per share.The Company’s annual dividend yield at the stock market closing price on January 20, 2017, was 2.1%. Connecticut Water has paid quarterly dividends on its common stock since its founding in 1956 without interruption or reduction and has increased dividend payments for each of the last 47 years. The Company’s Dividend Reinvestment Plan and Common Stock Purchase Plan (DRIP) is available to registered shareholders, employees, and residential customers of the Connecticut Water and Maine Water companies. Other investors who wish to participate in the DRIP should contact investor relations at the Company for more information. To learn more about investing in Connecticut Water, visit http://ir.ctwater.com. The Union League of Philadelphia
6/6/2017
5:30 PM - 9:00 PM
Annual Outing - Dinner - 2017 Details to follow. Bala Golf Club
6/6/2017
11:00 AM - 5:30 PM
Annual Outing - Golf - 2017 Details to follow. Bala Golf Club
5/17/2017
11:30 AM - 1:00 PM
UGI Corporation - 2017 Through subsidiaries, UGI Corporation operates natural gas and electric utilities in Pennsylvania, distributes propane both domestically and internationally, and manages midstream assets and engages in energy marketing in the Mid-Atlantic region. The Union League of Philadelphia
5/16/2017
11:30 AM - 1:00 PM
Remark Holdings, Inc. - 2017 Remark Holdings, Inc. (MARK) owns, operates and acquires innovative digital media properties across multiple verticals that deliver culturally relevant, dynamic content that attracts and engages users on a global scale. The company leverages its unique digital media assets to target the Millennial demographic, which provides it with access to fast-growing, lucrative markets. The company is headquartered in Las Vegas, Nevada, with additional operations in Los Angeles, California and in Beijing, Shanghai, Chengdu and Hangzhou, China. For more information, please visit the company's website at www.remarkholdings.com. The Racquet Club of Philadelphia
4/12/2017
11:30 AM - 1:00 PM
Xerium Technologies, Inc. - 2017 Xerium Technologies, Inc. (Xerium) is a manufacturer and supplier of over two types of consumable products used in the production of paper: machine clothing and roll covers. The Company markets its products through brands, such as Huyck Wangner, Weavexx, Stowe Woodward, Mount Hope, Robec and Xibe. The Company operates in two segments: machine clothing and roll covers. Its machine clothing segment products include various types of industrial textiles used on paper-making machines and manufactures spreader rolls. Through its roll covers segment, it manufactures various types of roll covers, refurbishes previously installed roll covers, provides mechanical services for the internal mechanisms of rolls used on paper-making machines, and manufactures spreader rolls. In addition, its products are also installed in other industrial applications, such as non-woven and fiber cement machines. The Union League of Philadelphia
2/27/2017
11:30 AM - 1:00 PM
FUDA Group USA - 2017 The Racquet Club of Philadelphia
2/15/2017
11:30 AM - 1:00 PM
Liberty Star Uranium & Metals Corp. - 2017 Liberty Star Uranium & Metals Corp. (LBSR: OTCBB) (LBSR: OTCPK) is an Arizona-based mineral exploration company engaged in the acquisition, exploration, and development of mineral properties in Arizona and the southwest USA. Currently the company controls properties which are located over what management considers some of North America’s richest mineralized regions for copper, gold, silver, molybdenum (moly), and uranium. The Hay Mountain copper property is Liberty Star's key immediate focus. http://www.libertystaruranium.com/ The Racquet Club of Philadelphia
12/19/2016
5:30 PM - 7:30 PM
PSA Annual Holiday Party - 2016 Pyramid Club 1735 Market Street 52nd Floor Philadelphia, PA 19103 http://www.clubcorp.com/Clubs/Pyramid-Club Pyramid Club, 1735 Market St, Philadelphia, PA 19103
12/12/2016
11:30 AM - 1:00 PM
AstraZeneca PLC - 2016 AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company?s marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It primarily serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Eli Lilly and Company; Heptares Ltd.; French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom. AstraZeneca PLC operates as a subsidiary o The Racquet Club of Philadelphia
11/3/2016
11:30 AM - 1:00 PM
Roche Holding, Ltd. - 2016 Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry seven years in a row by the Dow Jones Sustainability Indices. The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2015 employed more than 91,700 people worldwide. In 2015, Roche invested CHF 9.3 billion in R&D and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com. All trademarks used or mentioned in this release are protected by law. The Union League of Philadelphia
10/27/2016
5:00 PM - 8:30 PM
PSA Annual Meeting - 2016 Business Session 5:00-5:45pm Reception 5:45-6:30pm Dinner 6:30-8:30pm YOU MUST ATTEND THE BUSINESS SESSION IN ORDER TO ATTEND THE RECEPTION AND DINNER The Union League of Philadelphia
10/18/2016
11:30 AM - 1:00 PM
Ritter Pharmaceuticals, Inc. - 2016 Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) is a pharmaceutical company developing novel therapeutic products to treat gastrointestinal diseases with an initial focus on lactose intolerance. Ritter expects to be the first FDA approved drug for the treatment of lactose intolerance. Other highlights: • RP-G28, Ritter's lead product, has been studied in a Phase 2a trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide • Phase 2b/3 underway, potential pivotal trial: Enrollment completed - Data readout expected in Q1 2017 • Unmet need with no FDA-approved drugs - $1.2 billion U.S. market opportunity for an Rx treatment • Limited physician and user satisfaction with current therapies (i.e.: avoidance of dairy foods or use of short-term lactase supplements or alternative dairy foods, such as Soy Milk and Non-dairy foods) • Strong intellectual property portfolio and NCE status. Ritter Pharma has 9 issued patents providing coverage through 2030. An additional 24 patent applications are pending in the U.S. and other key international markets. The Racquet Club of Philadelphia
10/13/2016
11:30 AM - 1:00 PM
RPM International, Inc. - 2016 RPM International Inc., a holding company, owns subsidiaries that are world leaders in specialty coatings, sealants, building materials and related services serving both industrial and consumer markets. Fiscal 2012 sales were $3.8 billion. RPM’s industrial products include roofing systems, sealants, corrosion control coatings, flooring coatings and specialty chemicals. Industrial brands include Stonhard, Tremco, illbruck, Carboline, Flowcrete, Universal Sealants, Fibergrate and Euco. RPM’s consumer products are used by professionals and do-it-yourselfers for home maintenance and improvement and by hobbyists. Consumer brands include Zinsser, Rust-Oleum, DAP, Varathane and Testors. Additional details can be found at www.RPMinc.com and by following RPM on Twitter at www.twitter.com/RPMintl The Racquet Club of Philadelphia, 215 S. 16th St., Philadelphia, PA 19102
10/5/2016
11:30 AM - 1:30 PM
Monmouth Real Estate Investment Corp., UMH Properties, Inc. 10/5/16 - 2016 PLEASE NOTE: THIS EVENT WILL GO UNTIL 1:30 PM. Monmouth Real Estate Investment Corporation, founded in 1968 is one of the oldest public equity REITs in the U.S. The Company specializes in single-tenant, net-leased industrial properties, subject to long-term leases, primarily to investment grade tenants. Monmouth Real Estate Investment Corporation is a fully-integrated and self-managed real estate company, whose property portfolio consists of 99 properties located in 30 states, containing a total of approximately 16 million rentable square feet. In addition, the Company owns a portfolio of REIT securities. For additional information, please visit the Company’s website at www.mreic.reit. UMH Properties, Inc., which was organized in 1968, is a public equity REIT. The Company owns and operates 100 manufactured home communities containing approximately 18,000 developed homesites. These communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana and Michigan. In addition, the Company owns a portfolio of REIT securities. For additional information, please visit the Company’s website at www.umh.reit. PLEASE NOTE: THIS EVENT WILL GO UNTIL 1:30 PM. The Union League of Philadelphia
9/13/2016
11:00 AM - 1:00 PM
PixarBio - 2016 The Union League of Philadelphia
7/13/2016
11:30 AM - 1:00 PM
American Gas Association - 2016 The American Gas Association, founded in 1918, represents more than 200 local energy companies that deliver clean natural gas throughout the United States. There are more than 71 million residential, commercial and industrial natural gas customers in the U.S., of which 94 percent — over 68 million customers — receive their gas from AGA members. Today, natural gas meets almost one-fourth of the United States’ energy needs. The Union League of Philadelphia
6/30/2016
11:30 AM - 1:00 PM
VistaGen Therapeutics, Inc. - 2016 VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the CNS. VistaGen's lead product candidate, AV-101, is a next generation, orally available prodrug in Phase 2 development, initially for the adjunctive treatment of MDD in patients with an inadequate response to standard antidepressants. AV-101 is currently being evaluated in an ongoing Phase 2a clinical study being conducted by Principal Investigator, Dr. Carlos Zarate, Chief, Section on the Neurobiology and Treatment of Mood Disorders and Chief of Experimental Therapeutics and Pathophysiology Branch at the U.S. National Institute of Mental Health (NIMH), and fully funded by the NIMH. The Racquet Club of Philadelphia, 215 S. 16th St., Philadelphia, PA 19102
6/20/2016
11:30 AM - 1:00 PM
Paringa Resources, Ltd. - 2016 Paringa Resources Ltd (ASX:PNL, OTCQX: PNGZF) is an emerging US based energy provider developing the high margin, low capex Buck Creek Mining Complex located in the growing Illinois Coal Basin. Recent highlights include: (i) Emergence of the Buck Creek No.2 Mine has transformed the economics of the Buck Creek Mine Complex and a new staged development strategy will ultimately allow Paringa to become a 5.6 Mtpa supplier of high quality coal into the growing Eastern US power market, with capex to initial production of only US$44 million; (ii) Execution of a cornerstone coal sales agreement with LG&E and KU, two of the largest fuel buyers within the Company’s initial target Ohio River Market, with future contracted coal sales totalling US$220 million over a 7year contract period; (iii) Completion of a Scoping Study which confirmed that the Buck Creek No.2 Mine will be a high margin 1.8 million tons per annum (“Mtpa”) mine with extremely low capex of only US$44 million due to favourable geology and shallow depth of coal seam from surface at the proposed No.2 Mine site; (iv) Completion of a Bankable Feasibility Study which confirmed that Buck Creek No.1 Mine will be a high margin 3.8 Mtpa mine and will generate average earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of over US$87 million per annum, even at current depressed coal prices; (v) Completion of a share placement of 15 million shares to US institutional investors and Australian and New Zealand institutional and sophisticated investors to raise gross proceeds of A$5.1 million; AND (vi) Paringa’s ordinary shares commenced trading in the United States on the OTCQX® Best Market under the symbol “PNGZF”, enabling new and existing US investors to trade Paringa’s ordinary shares in US dollars. http://www.paringaresources.com/ The Racquet Club of Philadelphia, 215 S. 16th St., Philadelphia, PA 19102
6/14/2016
5:30 PM - 9:00 PM
Annual Outing - Dinner - 2016 5:30 – 7:00 p.m. Open Bar 7:00 – 9:00 p.m. Dinner with Wine Service All members attending must respond by Friday, June 3, 2016. Guests are welcome at a cost of $100.00. If qualified for membership, an additional $50.00 will entitle a guest to PSA membership. The guest will need to fill out the online membership application on the PSA website. Please make all checks payable to the Philadelphia Securities Association and mail to: Joseph Nowak, PSA Treasurer Oppenheimer & Co. 1818 Market Street Suite 2430 Philadelphia, PA 19103 If you wish to play golf, please register on the separate Golf Registration link. If you need directions, please call Eric Gartland at (215) 656-2810 or (609) 502-6971. The Union League Golf Club, 3801 Grant Avenue, Philadelphia, PA 19114
6/14/2016
11:00 AM - 5:30 PM
Annual Outing - Golf - 2016 11:00 a.m. Golf registration, Driving, and Putting Practice 12:00 p.m. First Tee The club will provide a box lunch. Greens fees, including carts will be $175.00. The price for guests including golf, dinner, and gift is $275.00 This is a separate registration from the Dinner registration, which you should also do. Deadline for registration is Friday, June 10. Make checks payable to the Philadelphia Securities Association, and mail to: Joseph Nowak, PSA Treasurer Oppenheimer & Co. 1818 Market Street Suite 2430 Philadelphia, PA 19103 If you need directions, please call Eric Gartland at (215) 656-2810 or (609) 502-6971. The Union League Golf Club, 3801 Grant Avenue, Philadelphia, PA 19114
6/9/2016
11:30 AM - 1:00 PM
AmeriGas Partners, LP - 2016 Amerigas Partners, L.P. is a holding company. The Company conducts its business principally through its subsidiary, AmeriGas Propane, L.P. (AmeriGas OLP), a Delaware limited partnership. AmeriGas Propane, Inc. is the Company’s general partner (the General Partner) and is responsible for managing its operations. The General Partner is a wholly owned subsidiary of UGI Corporation (UGI), a publicly traded company. The Partnership serves approximately 2 million residential, commercial, industrial, agricultural, wholesale and motor fuel customers in all 50 states from over 2,000 propane distribution locations. In addition to distributing propane, the Partnership also sells, installs and services propane appliances, including heating systems. The Partnership sells propane primarily to residential, commercial/industrial, motor fuel, agricultural and wholesale customers. The Union League of Philadelphia
5/5/2016
5:30 PM - 7:00 PM
PUDO, Inc. - 2016 PUDO Inc. provides courier shipping services for online shoppers, university students, or home-based professionals worldwide. The company offers instore over the counter pick-up services. Its services are available in convenience stores, gas stations, and other variety stores, which allow registered courier companies and consumers to use these stores as pick-up locations for parcels and letters that require identification and/or signatures to release. The company serves its customers through a network of PUDO-authorized dealer pickup and drop-off locations in Canada and the United States. PUDO Inc. is based in Mississauga, Canada. The Racquet Club of Philadelphia
4/28/2016
11:30 AM - 1:00 PM
Artesian Resources Corporation - 2016 Artesian Resources Corporation (NASDAQ:ARTNA) provides essential water, wastewater services and related services throughout the Delmarva Peninsula through our regulated and non-regulated subsidiaries. Artesian Water Company, our primary subsidiary, is the oldest and largest investor owned public water utility on the Delmarva Peninsula and has been providing water service since 1905. We are a total water resource management company focused on identifying new and dependable sources of water supply, developing wells, and building and operating water and wastewater treatment plants. We offer a no-cost dividend reinvestment and cash purchase plan. Our recent dividend yield is approximately 3%. The Union League of Philadelphia
4/19/2016
11:30 AM - 1:00 PM
Cytori Therapeutics, Inc. - 2016 Cytori Therapeutics Cytori Cell TherapyTM (CYTX) is under evaluation in the United States for treatment of patients with hand and finger involvement due to the autoimmune condition scleroderma, as well as patients with symptomatic knee osteoarthritis. Their technology is approved in many countries around the world, and we have a number of active global partnerships with academic hospitals, companies and government agencies that share our interest in bringing Cytori Cell TherapyTM to patients in need. - See more at: Cytori Therapeutics, www.cytori.com The Racquet Club of Philadelphia
4/12/2016
11:30 AM - 1:00 PM
BiolineRX, Ltd. - 2016 BioLineRx is a publicly-traded (NASDAQ/TASE: BLRX), clinical-stage biopharmaceutical company based in Modi’in, Israel, dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization. BioLineRx’s close ties with universities, research institutes, academic institutions, technology transfer offices and biotechnology companies, both in Israel and globally, enable access to promising projects at an early stage. The first stage involves a stringent selection process. BioLineRx’s scientists specialize in evaluating potential drug candidates from both scientific and marketing perspectives. After acquiring the most promising projects, the Company then performs feasibility assessment studies and development through pre-clinical and clinical stages. Supported and assisted by a distinguished panel of scientific advisers, the Company’s scientists and experts in pharmacy and regulation, clinical trials and IP work together to advance BioLineRx’s pipeline usually through Phase II proof of concept in humans. And finally, the Company partners with medium size and large pharmaceutical companies to complete the clinical development and bring the product to market. The Racquet Club of Philadelphia
4/6/2016
11:30 AM - 1:00 PM
Connecticut Water - 2016 Connecticut Water is the largest publicly traded water utility based in New England. The Company is headquartered in Clinton, Connecticut and serves more than 123,000 customers, or about 400,000 people in 77 communities through its regulated water utility subsidiaries in the states of Connecticut and Maine. Connecticut Water has paid a dividend without interruption or reduction since its founding in 1956, and has increased dividend payments on its common shares for 46 consecutive years. The Union League of Philadelphia
3/21/2016
11:30 AM - 1:00 PM
UGI/Amerigas UGI Corporation is a holding company that, through subsidiaries, distributes, stores, transports and markets energy products and related services. We are a domestic and international retail distributor of propane and butane (which are liquefied petroleum gases (“LPG”)); a provider of natural gas and electric service through regulated local distribution utilities; a generator of electricity; a regional marketer of energy commodities; an owner and manager of midstream assets; and a regional provider of heating, ventilation, air conditioning, refrigeration and electrical contracting services. The Union League of Philadelphia
1/29/2016
11:30 AM - 1:00 PM
JRSIS Healthcare Corporation JRSIS HEALTHCARE CORPORATION - (JRSS- OTC - NO CURRENT MARKET ) operates Harbin Jiarun Hospital Company Limited (“Jiarun Hospital”) in Harbin in the Province of Heilongjiang of the People’s Republic of China (“PRC”). Jiarun is a 650 bed private hospital serving patients on a municipal and county level providing both Western and Chinese medical practices to the residents of Harbin. Jiarun specializes in the areas of Pediatrics, Dermatology, ENT, Traditional Chinese Medicine (TCM), Ophthalmology, Internal Medicine Dentistry, General Surgery, Rehabilitation Science, Gynecology, and General Medical Services. Its facilities and equipment are among the most modern in China. On a three (3) year basis, the company’s revenue has been growing at a compound rate of approximately 31% annually. Fourth quarter 2015 revenue was up 82% from the prior year. In 2015 the hospital was voted the Most Valuable Private Hospital in China by the Chinese Hospital Association. The Company is pursuing an acquisition strategy of hospitals and related medical service providers in other Chinese cities. The Company is a fully reporting US listed company. As of October 23, 2015 its shares were cleared for public trading. So far an active trading market has not developed. JRSIS HEALTHCARE is seeking support in developing an active US trading market for its shares. It is also seeking additional capital so as to pursue its acquisition program in China. www.jhcc.com The Racquet Club of Philadelphia
11/11/2015
5:00 PM - 8:30 PM
PSA Annual Meeting YOU MUST ATTEND THE BUSINESS SESSION IN ORDER TO ATTEND THE RECEPTION AND DINNER The Union League of Philadelphia
11/2/2015
11:30 AM - 1:00 PM
SITO Mobile, Ltd. SITO Mobile Limited is a technology based mobile solutions provider serving businesses, advertisers and brands. The company provides a mobile engagement platform that enables brands to increase awareness, loyalty and sales. The Racquet Club of Philadelphia
10/28/2015
11:30 AM - 1:00 PM
Staffing 360 Solutions, Inc. PCG Advisory would like to introduce you to Staffing 360 Solutions, a high growth public company in the global staffing sector engaged in the aggregation of international staffing organizations with operations in the United States and Europe. The Company is executing a buy-and-build strategy with a stated objective of $300 million in annualized revenue within the next 24 months (current annualized revenue run rate is ~$145 million). STAF also recently completed their uplisting to the Nasdaq. Recent Achievements Positive Adjusted EBITDA: Achieved in fiscal Q2 2015, two quarters ahead of schedule, and duplicated in Q3 2015. Positive Non-Adjusted EBITDA: Achieved in fiscal Q3 2015 for the first time, a significant milestone. $8 Million in Liabilities: Eliminated since Pathway to Profitability was initiated in September 2014. Cash Flow: Now generating positive cash flow from operations - forecast to continue for balance of fiscal 2015. Capital Raising: Closed $25 million working capital and $3 million term loan through MidCap Financial. Lighthouse Acquisition: Completed acquisition of engineering staffing firm generating revenue of $15 million, July 2015. The Racquet Club of Philadelphia
10/27/2015
11:30 AM - 1:00 PM
Roche Holding, Ltd. 10/27/15 Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, immunology, metabolism and neuroscience. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. In 2011, Roche had over 80,000 employees worldwide and invested over 8.1 billion Swiss francs ($9.1 billion) in research & development (R&D). The Group posted sales of 42.5 billion Swiss francs ($47.9 billion). For more information: www.roche.com. The Union League of Philadelphia
10/22/2015
11:30 AM - 1:00 PM
BioPharmX 10/22/15 BioPharmX™ Corporation is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter ("OTC"), and supplement applications in the health and wellness markets, including women's health and dermatology. The Racquet Club of Philadelphia
10/13/2015
11:30 AM - 1:00 PM
Revolution Lighting Technologies, Inc. 10/13/15 Revolution Lighting Technologies, Inc. is a leading LED lighting solutions company. The company designs, manufactures, markets and sells energy-efficient LED and conventional lighting solutions with a strong presence in the industrial, commercial and government markets in the United States, Canada, and around the world. Revolution Lighting has created an innovative, multi-brand, lighting company that offers a comprehensive product platform of high-quality interior and exterior LED lamps and fixtures with a focus on the developing market for LED lighting solutions. The Union League of Philadelphia
10/7/2015
11:30 AM - 1:00 PM
Great Basin Scientific, Inc. 10/7/15 Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. The company sells its diagnostic tests through a direct sales force in the United States, as well as through distributors in the European Union and New Zealand. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah. The Racquet Club of Philadelphia
10/6/2015
11:30 AM - 1:00 PM
Monmouth Real Estate Investment Corp., UMH Properties, Inc. 10/6/15 Monmouth Real Estate Investment Corporation, founded in 1968 and one of the oldest public equity REITs in the U.S., specializes in single-tenant, net-leased industrial properties, subject to long-term leases primarily to investment grade tenants. The Company is a fully integrated and self-managed real estate company, whose property portfolio consists of 82 properties located in 28 states, containing a total of approximately 11.1 million rentable square feet. In addition, the Company owns a portfolio of REIT securities. For additional information, please visit the Company’s website at www.mreic.com. UMH Properties, Inc., which was organized in 1968, is a public equity REIT. The Company owns and operates 88 manufactured home communities containing approximately 15,100 developed homesites. These communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana and Michigan. In addition, the Company owns a portfolio of REIT securities. For additional information, please visit the Company’s website at www.umh.com. The Union League of Philadelphia